๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

LEVODOPA THERAPY IN STRIATONIGRAL DEGENERATION

โœ Scribed by Andrews, JohnM.

Book ID
123572200
Publisher
The Lancet
Year
1972
Tongue
English
Weight
165 KB
Volume
300
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Cortical and brain stem hyperexcitabilit
Cortical and brain stem hyperexcitability in striatonigral degeneration
โœ Markus Kofler; Gregor K. Wenning; Werner Poewe ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 830 KB

Striatonigral degeneration (SND) represents a subtype of multiple system atrophy (MSA) clinically dominated by poor levodopa-responsive parkinsonism and variably associated with any combination of autonomic, pyramidal, or cerebellar symptoms and signs.' Many patients display tremor with superimposed

Increased iron content in the putamen of
Increased iron content in the putamen of patients with striatonigral degeneration
โœ S. Kato; S. Meshitsuka; E. Ohama; J. Tanaka; J. F. Llena; A. Hirano ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 674 KB

We measured the total content of iron, copper, zinc and manganese in the putamen of four patients with striatonigral degeneration (SND) and age- and gender-matched normal controls. The iron content in the SND patients was five times greater than in the controls. Electron microscopic histochemistry r